基因与过度嗜睡的相互作用表明阻断性睡眠呼吸暂停亚型的治疗目标
Pavithra Nagarajan1, Nuzulul Kurniansyah1, Jiwon Lee1
1Division of Sleep and Circadian Disorders, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
medRxiv : the preprint server for health sciences
|November 22, 2024
概括
阻塞性睡眠呼吸暂停 (OSA) 中的过度白天嗜睡 (EDS) 与影响呼吸暂停-呼吸暂停指数 (AHI) 的遗传变异相互作用. 这项研究确定了OSA的新遗传点,提供了潜在的治疗见解.
科学领域:
- 遗传学 遗传学 是一个
- 睡眠医学 睡眠医学
- 心血管健康 心血管健康
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 是一种复杂的睡眠障碍,具有重要的遗传成分.
- 过度的白天嗜睡 (EDS) 是一些OSA患者的持续症状,即使在治疗后,也与心血管风险增加有关.
- 了解遗传因素和EDS之间的相互作用对于识别不同的OSA亚型和相关的健康风险至关重要.
研究的目的:
- 调查EDS作为暴露变量的影响与OSA中呼吸暂停-呼吸暂停指数 (AHI) 相关的遗传变异.
- 为AHI进行第一个大规模的全基因组基因x环境相互作用分析,检查遗传标记物和EDS之间的相互作用.
- 探索不同性别和特定人群之间的这些相互作用.
主要方法:
- 汇集了来自7个群体和4个人口背景的11,500多名个体的全基因组测序数据.
- 为AHI进行全基因组基因x环境相互作用分析,以EDS作为暴露变量.
- 分析了所有性别的遗传相互作用,并分别对男性和女性进行分析.
主要成果:
- 确定了16个基因标,显示了与EDS相互作用的证据.
- 其中8个基因标 (CCDC3,MARCHF1,MED31,TMEM26,CPSF4L,PI4K2B,RAP1GAP,YY1) 是与OSA相关的新报告.
- 特定的基因被确定为与EDS在所有性别的相互作用,只有男性,只有女性.
结论:
- 该研究强调了在OSA患者中与EDS相互作用的新型遗传变异,有助于AHI严重程度.
- 确定的遗传点表明,与代谢途径 (例如,胰岛素耐药性) 和营养缺乏 (例如,胺) 有潜在的联系.
- 结果可能会为经历持续EDS和相关心血管风险的OSA患者提供有针对性的治疗策略.
相关概念视频
Management of Insomnia
231
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
231
Sedatives and Hypnotics Drugs: Miscellaneous Agents
146
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
146
Circadian Rhythms and Gene Regulation
4.0K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.0K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
135
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
135
Sleep-Wake Cycles
1.2K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.2K
Narcolepsy
92
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
92


